NICE recommends Trobalt for seizures

The U.K.'s NICE issued draft guidance recommending the use of Trobalt retigabine from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) as adjunctive treatment for partial onset seizures for adults who have epilepsy if other treatments have been ineffective or produced unmanageable side effects. The guidance said Trobalt should be used when patients have not responded well to the following drugs: carbamazepine, clobazam, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, sodium valproate and topiramate. ...